Caveolin-1 negatively regulates TRAIL-induced apoptosis in human hepatocarcinoma cells

Biochemical and Biophysical Research Communications

Volumn 378, Issue 1, 2009, Pages 21-26

  Zhao, Xiangxuan ^a,b   Liu, Yong ^a,b   Ma, Qi ^a,b   Wang, Xiaohui ^a   Jin, Haijing ^a   Mehrpour, Maryam ^a,d   Chen, Quan ^a,c  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c NANKAI UNIVERSITY   (China)

^d INSERM   (France)

Author keywords

Apoptosis; Caveolin 1 Caveolae; Death receptor 4; TRAIL

Indexed keywords

CAVEOLIN 1; DEATH RECEPTOR 4; FILIPIN; METHYL BETA CYCLODEXTRIN; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; SHORT HAIRPIN RNA;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CAVEOLA; CELL STRAIN HEPG2; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERNALIZATION; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CAVEOLIN 1; CELL LINE, TUMOR; HUMANS; LIVER NEOPLASMS; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, SMALL INTERFERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 56949098754     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.123     Document Type: Article

References (33)

1. Marsters S.A., Pitti R.A., Sheridan J.P., and Ashkenazi A. Control of apoptosis signaling by Apo2 ligand. Recent Prog. Horm. Res. 54 (1999) 225-234
2. Humphreys R.C., and Halpern W. Trail receptors: targets for cancer therapy. Adv. Exp. Med. Biol. 615 (2008) 127-158
3. Bonavida B., Ng C.P., Jazirehi A., Schiller G., and Mizutani Y. Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: the trail to non-toxic cancer therapeutics (review). Int. J. Oncol. 15 (1999) 793-802
4. Meurette O., Fontaine A., Rebillard A., Le M.G., Lamy T., Lagadic-Gossmann D., and manche-Boitrel M.T. Cytotoxicity of TRAIL/anticancer drug combinations in human normal cells. Ann. N.Y. Acad. Sci. 1090 (2006) 209-216
5. Stahlhut M., Sandvig K., and van D.B. Caveolae: uniform structures with multiple functions in signaling, cell growth, and cancer. Exp. Cell Res. 261 (2000) 111-118
6. Shaul P.W., and Anderson R.G. Role of plasmalemmal caveolae in signal transduction. Am. J. Physiol. 275 (1998) L843-L851
7. Chun M., Liyanage U.K., Lisanti M.P., and Lodish H.F. Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc. Natl. Acad. Sci. USA 91 (1994) 11728-11732
8. Mineo C., Ying Y.S., Chapline C., Jaken S., and Anderson R.G. Targeting of protein kinase Calpha to caveolae. J. Cell Biol. 141 (1998) 601-610
9. Cho C.H., Lee C.S., Chang M., Jang I.H., Kim S.J., Hwang I., Ryu S.H., Lee C.O., and Koh G.Y. Localization of VEGFR-2 and PLD2 in endothelial caveolae is involved in VEGF-induced phosphorylation of MEK and ERK. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H1881-H1888
10. Liu P., Ying Y., Ko Y.G., and Anderson R.G. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J. Biol. Chem. 271 (1996) 10299-10303
11. Lalor D., Liu P., and Hayashi J. Fas ligand is enriched in the caveolae membrane domains of thymic epithelial cells. Cell Immunol. 230 (2004) 10-16
12. Ko Y.G., Lee J.S., Kang Y.S., Ahn J.H., and Seo J.S. TNF-alpha-mediated apoptosis is initiated in caveolae-like domains. J. Immunol. 162 (1999) 7217-7223
13. Williams T.M., and Lisanti M.P. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am. J. Physiol. Cell Physiol. 288 (2005) C494-C506
14. Zundel W., Swiersz L.M., and Giaccia A. Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide. Mol. Cell Biol. 20 (2000) 1507-1514
15. Liu J., Lee P., Galbiati F., Kitsis R.N., and Lisanti M.P. Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation. Am. J. Physiol. Cell Physiol. 280 (2001) C823-C835
16. Ingueneau C., Huynh-Do U., Thiers J.C., Negre-Salvayre A., Salvayre R., and Vindis C. Caveolin-1 sensitizes vascular smooth muscle cells to mildly oxidized LDL-induced apoptosis. Biochem. Biophys. Res. Commun. 369 (2008) 889-893
17. Karam J.A., Lotan Y., Roehrborn C.G., Ashfaq R., Karakiewicz P.I., and Shariat S.F. Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence. Prostate 67 (2007) 614-622
18. Chen Q., Gong B., Mahmoud-Ahmed A.S., Zhou A., Hsi E.D., Hussein M., and Almasan A. Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood 98 (2001) 2183-2192
19. Li S., Song K.S., and Lisanti M.P. Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes. J. Biol. Chem. 271 (1996) 568-573
20. Czarny M., Lavie Y., Fiucci G., and Liscovitch M. Localization of phospholipase D in detergent-insoluble, caveolin-rich membrane domains. Modulation by caveolin-1 expression and caveolin-182-101. J. Biol. Chem. 274 (1999) 2717-2724
21. Fiorucci G., Vannucchi S., Chiantore M.V., Percario Z.A., Affabris E., and Romeo G. TNF-related apoptosis-inducing ligand (TRAIL) as a pro-apoptotic signal transducer with cancer therapeutic potential. Curr. Pharm. Des. 11 (2005) 933-944
22. Qin J.Z., Bacon P., Panella J., Sitailo L.A., Denning M.F., and Nickoloff B.J. Low-dose UV-radiation sensitizes keratinocytes to TRAIL-induced apoptosis. J. Cell Physiol. 200 (2004) 155-166
23. Ono K., Iwanaga Y., Hirayama M., Kawamura T., Sowa N., and Hasegawa K. Contribution of caveolin-1 alpha and Akt to TNF-alpha-induced cell death. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2004) L201-L209
24. Tso C.L., McBride W.H., Sun J., Patel B., Tsui K.H., Paik S.H., Gitlitz B., Caliliw R., van O.A., Wu L., deKernion J., and Belldegrun A. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Cancer J. 6 (2000) 220-233
25. Monier S., Dietzen D.J., Hastings W.R., Lublin D.M., and Kurzchalia T.V. Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol. FEBS Lett. 388 (1996) 143-149
26. Podar K., Tai Y.T., Cole C.E., Hideshima T., Sattler M., Hamblin A., Mitsiades N., Schlossman R.L., Davies F.E., Morgan G.J., Munshi N.C., Chauhan D., and Anderson K.C. Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells. J. Biol. Chem. 278 (2003) 5794-5801
27. Liu J., Garcia J.E., and Baramki T.A. The difference in outcome of in-vitro culture of human testicular spermatozoa between obstructive and non-obstructive azoospermia. Hum. Reprod. 11 (1996) 1587-1588
28. Garcia-Cardena G., Oh P., Liu J., Schnitzer J.E., and Sessa W.C. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc. Natl. Acad. Sci. USA 93 (1996) 6448-6453
29. Robinson J.M., and Badwey J.A. The NADPH oxidase complex of phagocytic leukocytes: a biochemical and cytochemical view Histochem. Cell Biol. 103 (1995) 163-180
30. Simionescu N., Simionescu M., and Palade G.E. Permeability of muscle capillaries to exogenous myoglobin. J. Cell Biol. 57 (1973) 424-452
31. Schnitzer J.E., Oh P., Pinney E., and Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J. Cell Biol. 127 (1994) 1217-1232
32. Botos E., Klumperman J., Oorschot V., Igyarto B., Magyar A., Olah M., and Kiss A.L. Caveolin-1 is transported to multivesicular bodies after albumin-induced endocytosis of caveolae in HepG2 cells. J. Cell Mol. Med. (2007)
33. Stan R.V., Roberts W.G., Predescu D., Ihida K., Saucan L., Ghitescu L., and Palade G.E. Immunoisolation and partial characterization of endothelial plasmalemmal vesicles (caveolae). Mol. Biol. Cell 8 (1997) 595-605